Literature DB >> 10598187

Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy.

I L Nilsson1, J Aberg, J Rastad, L Lind.   

Abstract

BACKGROUND: Primary hyperparathyroidism (HPT) is accompanied by hypertension and a cardiovascular mortality. Impaired endothelium-dependent vasodilatation (EDV) occurs in hypertension but has not been fully investigated in HPT despite the vasoactive influences of parathyroid hormone.
METHODS: Twenty-five HPT patients and 25 normocalcemic control subjects, matched for age and gender, underwent forearm venous occlusion plethysmography. EDV and endothelium-independent vasodilatation (EIDV) were evaluated during local infusion of metacholine (2 and 4 micrograms/min) and nitroprusside (5 and 10 micrograms/min), respectively. The endothelial function index was calculated as the ratio of forearm blood flows during the high doses of metacholine and nitroprusside. Ambulatory 24-hour blood pressures and thickness of the intima-media complex of the carotid arteries were also measured; the latter is considered an early marker of atherosclerosis.
RESULTS: Endothelial function index was lower in the HPT patients compared with control subjects (1.01 +/- 0.26 vs 1.27 +/- 0.31, P = .003). Reinvestigation 10 months after parathyroidectomy showed normalization of the index (1.31 +/- 0.39, P = .01) due to a numeric increase in EDV and decrease in EIDV. The carotid intima-media thickness and blood pressure were similar in the groups and unaltered postoperatively.
CONCLUSIONS: Endothelial vasodilatory dysfunction is another indicator of the vascular disturbance of HPT and can be normalized by parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598187     DOI: 10.1067/msy.2099.101422

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  33 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  J Rastad
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging.

Authors:  Cecilia Marini; Massimo Giusti; Riccardo Armonino; Giorgio Ghigliotti; GianPaolo Bezante; Lara Vera; Silvia Morbelli; Elena Pomposelli; Michela Massollo; Patrizia Gandolfo; Francesco Minuto; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-04       Impact factor: 9.236

3.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

4.  Elevation of parathyroid hormone levels in atrial fibrillation.

Authors:  Michiel Rienstra; Steven A Lubitz; Michael L Zhang; Rebecca R Cooper; Patrick T Ellinor
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

5.  Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats.

Authors:  J Ruth Wu-Wong; William Noonan; Masaki Nakane; Kristin A Brooks; Jason A Segreti; James S Polakowski; Bryan Cox
Journal:  Int J Endocrinol       Date:  2010-02-10       Impact factor: 3.257

6.  Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy.

Authors:  P Farahnak; M Ring; K Caidahl; L-O Farnebo; M J Eriksson; I-L Nilsson
Journal:  Eur J Endocrinol       Date:  2010-06-18       Impact factor: 6.664

7.  Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients.

Authors:  Alper Kepez; Ayla Harmanci; Tuncay Hazirolan; Mehlika Isildak; Ugur Kocabas; Ahmet Ates; Orcun Ciftci; Lale Tokgozoglu; Alper Gürlek
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-11       Impact factor: 2.357

Review 8.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 9.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

10.  Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism.

Authors:  A Ekmekci; N Abaci; N Colak Ozbey; A Agayev; N Aksakal; H Oflaz; N Erginel-Unaltuna; Y Erbil
Journal:  J Endocrinol Invest       Date:  2009-07-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.